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Backgeound." Large increases m left ventncular (LV) ca w volume after my- 
ocardtal infarct~n can lead Io head failure and death. Reversal of volume 
increases by excismn of the expanded scar and subsequent reconnection of 
viable myocan:lium ay result in signtr, cant ca~ac distortion. Scar exctSmn 
followed by insertion of a prosthetic graft restons the original geometry; hew- 
ever. introduces foreign materials into the body. A method of reducing cap, nty 
volume without such pnblems was attempted by shJnLing the aneurysm 
with laser energy. 
Methods: Rats (n = 14) underwent permanent coronary occlusion and 4 
weeks later were nndomized to either control (no treatment) or la~er therapy 
(irradiation of the surface of the scar until shnnkage was apparent). Thirty 
minutes after treatment, the hearts were removed, fixed at a distending 
pressun o! 15 mmHg, and the LV cavity volume measur~":l.. Intact size 
(assessed from the amount of remaining muscle) and scar thickness were 
measured from histologic sections, as was the extent of thermal effects and 
the waviness of the collagen fibers. 
Results: Both groups had similar sized large infarcts (P = NS). However, 
then was a 25% reduction in LV cavity volume from 0.72 :k 0.07 mL in controls 
fo 0.54 ~ 0.05 mL in laser-treated hearts (P < 0.05). Also, scar thickness was 
gnater in laser-treated hearts (550 ± 50pro) than in controls (360 ± 40/=m, P 
< 0.02). Laser treatment resulted in thermally induced shrinkage of collagen 
fibers in the aneurysm. The fibers directly affected appeared less bnght than 
controls wren V~Ned with IX~r~zed Itgtlt (an nldca~:~ of ir, cma~d ~ .  
aturo) and wen also shod~ ~ stra~lht~r than ~naL  Futlt'4mIx~e, ven 
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White amJo~ (AMLO) had a neut~l elfecl o~ overall moraMy and lecl to 
~c'ma~d me~a~, among pa~e~ (pts) w~ no.scampi co~om,mpa~y 
(CM) m PRAISE, (AMLO) we= assoc~led with mcnase~ number of 
PuJmonaW edema events (PE~). To ~ eluc¢late em appamm assocla- 
~on bellmen AMLO and mcn~sed PEI. m mmnts wem chamclmized 
and ~lass~ed using pmspecttied ¢finK~ crite~a m a blinded ~ .  pts 
with PEs Imaled with AMLO ~r PL (~d not ~fte~ w~h mga~ to ~ 
features, heserme NYItA clan. qectmn fracl~n or nonca~¢fmc lnggers. Pm- 
Por~o~ ol pls w~h PEs who had mchem CM did not (~er for AMLO (0.67) 
o~ PL (0.66). Using pu~random,~tion Man~-Bayer su~al  c .~m for I~  
~m PEs on both AMLO and PL, I1 ~ dBchne m survival (50%) Over Itm 
hrS. 3 ~ ~; di~le,,'1~l. By appmmmate~ I year, .~urv~val ~ tot pls 
wilh PEs paragel pts w#nout PEs. Among pts w~th ~ wflhout PEs, pls on 
AMLO had n,npmved sunmral. Excess PEs for AMLO ~ PL using b~ded 
re~ass~N:ation (8.4 vS 6_5%) w~ sim~lar to ~ seen for pn~ ffwestigator 
events (11A ~ 8.8) or for PRAISE adludicated endpoints. (6.1 vs 
26%) 
Co~lus~n: The mcreasecl PIE's m AMLO I~S m PRAISE is unexplained 
by clir~cal c h a ~ ,  mck~nng ~sce~c e~meo~ o,r me c~e~a by wh~,h 
PEs an  defined. Pts with PEs on AMLO have ~ sunnval compared 
wffh those on PL 
~ ACIE-Inhibiflon Improves the. Pulmonary Diffusion 
in Heart Failure by Reducing the EIcesslve 
Alveo lar -CN~my Memmne Diffushm Res;~;i~ce 
M. Guaz~. P.G Agostoni. M.D. Guaz~. Instrrute ot CanlK)lo~, Lh,;,~,sn'y ot 
Mdar~ CN.R. Milan. tlaly 
Oblecfwes: TINs study was am~ed at investigatir~g the mechanisms whereby 
ACE-int~b~on Fnl~ove the reduced pulmonary diffusing capacffy for cad~n 
monoxide (Dlco) in chrorec head fmlure (CHF). 
Background: Ah,,eolar-capdlary membrane conductance (DM) and cap- 
irlary blood ~olume (Vc) are tho s u ~ t s  of Dlco. In CHF, stret~ 
failere of the rnembrane provides a pessible mechanism for reduced DM and 
subsequent impairemem of Dlco. 
Mefho0~: 27 iTdt~ents wffh NYHA class II to lit CHF and 14 age-and 
sex-malched non.el sub]ects underemnt pulmonary foncbon Testing ~ 
determmason of DM and Vc eccom~ng to the cla,ss¢ Rougt~on and Foster 
method, whik~ receiving placebo and 48 hours and 8 weeks after starling 
enalapril tnalment (10 mcj b.Ld.). 
Resuffs: Enala~onl was ~efteclwe in controls at both short and mid-term. 
In CHF, the only change observed at short.ter'~n was a reduc~on m Vc (from 
134.5 ± 49.5 to 120 ± 36.2. p < 0,05) (likely consequence of a decrease 
in capillary pulmonary pressure). At mid.term DM was greatly rained (from 
29.51 ~ 8.0 to 36.9 ~: 8.9 ml/min,'mmHg, p ~ 0,01) even when the effective 
alveolar volume (Val was accounted for (DM/Va) resulting in a significant 
improvement in Dlco (form 22.1 ± 6.7 to 25.2 ± 5.5. mVmtn/mmHg, p < 
0.01), desptto a decrease in Vc (from 134.5 ± 49.5 to 101.3 ± 44.2 ml, p < 
0.01). The delay in DM improvement suggests the emergence of a gradual 
speofic modulatory effect of ACE.inhibition on the membrane function, which 
is likely disr~oafed from changess in pulmonary capdlary pressure and Vc. 
Conclusions: CHF causes an increase in diffusive resistance through 
derangement of alveolar-capillary interface. ACE-inhibition restores the dif- 
fusive propen'~es of the membrane and gas transfer, and protects the lung 
when the head is failing. 
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